Director, KAT6i (Prifetrastat) Launch Lead, US Breast Cancer

Pfizer•Collegeville, PA
•$176,600 - $294,300•Hybrid

About The Position

Pfizer Commercial Oncology is preparing to launch prifetrastat, Pfizer’s first-in-class oral KAT6 inhibitor, in development with fulvestrant for adults with previously treated HR+/HER2- metastatic breast cancer. The Director will lead US launch readiness, owning an integrated launch plan across the brand team, market development, access, and operations and driving cross-functional milestones from pre-launch through approval and first patient. The role aligns the US plan with global strategy and works closely with Commercial, Medical, Legal, Regulatory, Market Access, Supply, Sales, and Global teams. It reports to the US IBRANCE / BC Pipeline Brand Lead; responsibilities may evolve with business needs and individual interest. This marketing and launch leadership role is suited to someone who can solve complex problems in a competitive market, operate effectively in a fast-paced, matrixed environment, influence without direct authority, and bring structure to ambiguity. The leader will shape how prifetrastat reaches customers at launch, including the coordination of field, omnichannel, and digital engagement and the capabilities to build ahead of approval. The role leads the integrated launch plan; translates brand strategy and OGSM into owned workstreams; plans compliant unbranded market development; coordinates operational readiness; maintains launch scenarios and risk mitigations; and reports launch health through KPIs and senior-leadership updates. It also leads resource planning through the operating plan process and develops practical AI-enabled approaches to launch planning and execution in partnership with Digital, Data Science, Legal, and Compliance. The position is hybrid, with 2 to 3 days per week on site, and may be based in New York, NY, or Collegeville, PA. Travel is up to 10–15% based on business needs. Relocation assistance may be available based on business needs and/or eligibility, but the posting separately states that the role is not eligible for a relocation package.

Requirements

  • BA/BS degree required.
  • At least 8 years of pharmaceutical, biotech, or healthcare commercial experience, including launch management, integrated marketing operations, and cross-functional project leadership; alternatively, a master's degree with at least 7 years of experience.
  • Ability to run multiple concurrent workstreams, stakeholders, and deadlines with high attention to detail and bring structure to ambiguity, including a brand launch with no fixed playbook.
  • Strong oncology/pharmaceutical commercial knowledge and analytical fluency to connect performance insights to execution and investment decisions.
  • Clear and effective communication skills, with the ability to build trust across functions and with external partners without relying on direct authority.
  • Compliance mindset and experience operating within promotional review, procurement, and financial policy requirements.
  • Breadth of diverse leadership experiences and capabilities, including the ability to influence and collaborate with peers, achieve meaningful outcomes, and create business impact.
  • Permanent work authorization in the United States.

Nice To Haves

  • Oncology experience, ideally in breast cancer.
  • Prior launch experience, including pre-approval market development.
  • Experience working with global marketing teams.

Responsibilities

  • Lead the US cross-functional launch team and own the integrated launch plan from pre-launch through approval and first patient.
  • Set launch milestones, ways of working, and meeting cadence, and deliver stage-gate and governance requirements on time.
  • Identify cross-functional interdependencies early and escalate and resolve issues that threaten launch readiness or timing.
  • Translate brand strategy and OGSM into owned, dated workstreams addressing differentiation in the post-CDK4/6 landscape, biomarker-testing readiness, tolerability and dose-management support, and customer value.
  • Assign each launch-critical issue an owner and deliverable linked to relevant evidence, insights, and market research.
  • Plan and sequence compliant, unbranded market development within pre-approval guardrails, including a shared HR+/HER2- platform with other Pfizer breast cancer assets.
  • Partner with Legal, Regulatory, Medical, and Compliance to ensure activities are compliant.
  • Coordinate market research, advisory boards, KOL engagement, and congress plans so insights inform launch decisions in time.
  • Partner with Supply, Regulatory, and Market Access to make timely US readiness decisions, including pack configuration, artwork, and channel setup.
  • Provide commercial input to decisions with pricing and access consequences, including dose strengths and pack format, and bring them to governance early enough for action.
  • Track supply-side milestones against the US plan to align commercial and supply timelines.
  • Maintain launch scenarios for approval timing, standard-of-care changes, and competitor entry, with an owner and decision date for each.
  • Pressure-test launch assumptions as data and the market evolve, define triggers for plan changes, and maintain mitigations for timeline acceleration or market shifts.
  • Build a launch KPI dashboard and report readiness to senior leadership on a regular cadence.
  • Align with the Global Launch Team and the atirmociclib and IBRANCE teams on narrative, investment, and customer engagement.
  • Lead resource planning through the operating plan process, including team and budget ramp-up as launch approaches.
  • Develop new approaches where no established playbook exists, particularly for AI and the go-to-market model.
  • Identify and pilot practical AI uses in launch planning and execution, such as insight synthesis, scenario modeling, and content development, working with Digital, Data Science, Legal, and Compliance to ensure responsible use.

Benefits

  • 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution.
  • Paid vacation, holiday, and personal days.
  • Paid caregiver/parental and medical leave.
  • Medical, prescription drug, dental, and vision coverage.
  • Eligible to participate in Pfizer’s Global Performance Plan, with a bonus target of 20% of base salary.
  • Eligible to participate in a share-based long-term incentive program.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service